#United States #New York #Faruqi & Faruqi #securities claims #Hims & Hers

Faruqi & Faruqi, LLP Investigates Hims & Hers Health

Faruqi & Faruqi, LLP, a well-known national securities law firm, has recently announced an investigation into the potential claims that may arise against Hims & Hers Health, Inc., also referred to as Hims. This investigation will specifically focus on possible misstatements and omissions made by the company that could have adversely impacted its investors.

Background

Faruqi & Faruqi has been in the forefront of securities law matters since its inception in 1995. With a robust history of recovering hundreds of millions of dollars for defrauded investors, the firm continues to play a crucial role in holding companies accountable for their actions. Investors who purchased Hims securities between April 29, 2025, and June 22, 2025, are particularly encouraged to come forward and discuss their legal rights with the firm.

Investigation Details

The firm’s investigation stems from a class action lawsuit filed against Hims & Hers Health, with a deadline for potential lead plaintiff applications set for August 25, 2025. This lawsuit asserts that Hims and its executives may have violated federal securities laws by disseminating false or misleading statements regarding their operations, specifically in relation to their promotion and sale of medications. The lawsuit claims that Hims was involved in the “deceptive promotion” of illegitimate versions of the drug Wegovy, posing significant risks to patient safety.

On June 23, 2025, Hims faced a monumental set back when Novo Nordisk announced the termination of its partnership with the company. The partnership was reportedly dissolved because Hims did not comply with legal standards, leading to a considerable decline in its stock prices – a staggering drop of 34.6%. This event has left many investors facing substantial losses, prompting an urgent call for those affected to explore their options with the help of legal professionals.

Call to Action

James (Josh) Wilson, a Senior Partner at Faruqi & Faruqi, encourages any investor who has suffered losses connected to Hims to reach out for a discussion regarding their rights and options. Investors looking to preserve their claims are reminded that the court will appoint a lead plaintiff based on the financial interest and the typicality of the claims brought by the investors.

Faruqi & Faruqi also welcomes information from anyone who might have witnessed deceptive practices at Hims, including whistleblowers, former employees, and shareholders. Those interested in following the case or needing further details can access resources by visiting Faruqi Law or by contacting the firm directly.

Conclusion

As the investigation unfolds, many investors are left to wonder how these allegations will affect not only their personal finances but the company's future as well. Faruqi & Faruqi are committed to ensuring that investors have their voices heard, and they stand ready to pursue any claims vigorously. This case serves as a reminder of the necessity for transparency and integrity in the corporate sector, emphasizing the rights of investors everywhere to seek justice and accountability.